Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice (Q40147948)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 December 2006

Language	Label	Description	Also known as
English	Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice	scientific article published on 28 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice (English)

1 reference

Europe PubMed Central

17 September 2017

author name string

Shuxia Song

1

1 reference

Europe PubMed Central

17 September 2017

Fang Wang

2

1 reference

Europe PubMed Central

17 September 2017

Xiaowen He

3

1 reference

Europe PubMed Central

17 September 2017

Ying He

4

1 reference

Europe PubMed Central

17 September 2017

Dean Li

5

1 reference

Europe PubMed Central

17 September 2017

Shuhan Sun

6

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

28 December 2006

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

25

1 reference

Europe PubMed Central

17 September 2017

25

1 reference

Europe PubMed Central

17 September 2017

4853-4860

1 reference

Europe PubMed Central

17 September 2017

In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Identification of two naturally presented MAGE antigenic peptides from a patient with hepatocellular carcinoma by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.029

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.12.029

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40147948&oldid=1886853940"